Image source: The Motley Fool.
CorMedix Inc Common Stock (NASDAQ: CRMD)
Q2 2022 Earnings Call
Aug 11, 2022 , 8:30 a.m. ET
Operator
For further details see:
CorMedix Inc Common Stock (CRMD) Q2 2022 Earnings Call TranscriptImage source: The Motley Fool.
CorMedix Inc Common Stock (NASDAQ: CRMD)
Q2 2022 Earnings Call
Aug 11, 2022 , 8:30 a.m. ET
Operator
For further details see:
CorMedix Inc Common Stock (CRMD) Q2 2022 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the Center for Medicare & Medicaid Service...
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced DefenCath® (taurolidine and heparin) catheter ...
BERKELEY HEIGHTS, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therap...